Intended Use
It is used for in vitro quantitative detection of Aβ1-42 content in human serum.
Alzheimer's disease (AD), also known as Alzheimer's disease, is a common degenerative disease of the central nervous system. The main clinical manifestations are progressive memory loss, cognitive dysfunction, and personality changes. The main pathological features of AD include senile plaques (SP) formed by aggregation of β-amyloid (Aβ) in the cerebral cortex and hippocampus, neurofibrillary tangles formed by abnormal aggregation of Tau protein, and cerebral cortex and hippocampus. Decrease of nerve cells. Aβ is the main component of senile plaques and plays a key role in the pathogenesis of AD. Aβ has a neurotoxic effect, can damage cholinergic neurons, cause nerve cell apoptosis, produce peroxide damage, and stimulate inflammation. Commonly used clinical and laboratory Aβ1-42 detection methods include chemiluminescence, immunochromatography and enzyme-linked immunoassay.

Specifications

Main Components

1. Aβ1-42 test strip in a sealed pouch with desiccant....................25 tests
2. QR code card for calibration.........................................................1 piece
3. User manual.................................................................................1 piece
4. Quantitative suction and dropping tube (Optional).

Storage And Validity

1. Store the test kit at 4℃~30℃ up to the expiration date printed on package.
2. Test strip should be used within 1 hour once the foil pouch is opened.

Applicable Device

1. LS-1100 Dry Fluorescence Immunoassay Analyzer
2. LS-2100 Dry Fluorescence Immunoassay Analyzer
3. LS-4000 Dry Fluorescence Immunoassay Analyzer
4. LS-3000 Automatic Fluorescence Immunoassay Analyzer